voriconazole has been researched along with Onychomycosis in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (25.00) | 29.6817 |
| 2010's | 5 (31.25) | 24.3611 |
| 2020's | 7 (43.75) | 2.80 |
| Authors | Studies |
|---|---|
| Gupta, AK; Talukder, M; Venkataraman, M | 1 |
| Amorim, GMW; Andrade-Júnior, FP; Duarte, SS; Ferreira, RC; Gouveia, RG; Lima, EO; Medeiros, CIS; Oliveira, NR; Oliveira-Filho, AA; Silva, DKF | 1 |
| Hustrini, NM; Panggabean, SD | 1 |
| El-Hawary, EE; Fawzy, MM; Nofal, A | 1 |
| Guarro, J; Pérez-Cantero, A | 1 |
| Akbari, F; Deng, S; Houbraken, J; Najafzadeh, MJ; Naseri, A; Wang, X; Xu, X; Zhang, H; Zhao, R | 1 |
| Alonso, A; Anjos, JLV; da Rocha, PBR; de Faria, DLA; Gil, OM; Gratieri, T; Kloppel, LL; Krawczyk-Santos, AP; Marreto, RN; Souza, BDS; Taveira, SF | 1 |
| Corrêa, C; Fuentefria, AM; Goldani, LZ; Heidrich, D; Rosa, PD; Scroferneker, ML; Vettorato, G | 1 |
| Chen, H; Chen, M; Liao, W; Pan, W; Zhou, J | 1 |
| Akiti, T; Barreiros, G; Nouér, SA; Nucci, M; Trope, BM; Varon, AG | 1 |
| Bueno, JG; Gallego, M; Martinez, C; Mesa, AC; Sanclemente, G; Zapata, B | 1 |
| Vera-Cabrera, L; Welsh, E; Welsh, O | 1 |
| Selleslag, D | 1 |
| Borrego, L; Hernández, J; Hernández-Machín, B; Islas, D; Martín, AM; Peñate, Y | 1 |
| Sellart-Altisent, M; Torres-Rodríguez, JM | 1 |
| Cárdenes, CD; Carrillo-Muñoz, AJ; del Valle, O; Estivill, D; Giusiano, G; Guardia, C; Guarro, J; Quindós, G; Rodríguez, V | 1 |
4 review(s) available for voriconazole and Onychomycosis
| Article | Year |
|---|---|
Review of the alternative therapies for onychomycosis and superficial fungal infections: posaconazole, fosravuconazole, voriconazole, oteseconazole.
Topics: Antifungal Agents; Complementary Therapies; Dermatologic Agents; Foot Dermatoses; Humans; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine; Treatment Outcome; Voriconazole | 2022 |
Sarocladium and Acremonium infections: New faces of an old opportunistic fungus.
Topics: Acremonium; Animals; Antifungal Agents; Arthritis; Blood; Central Nervous System Infections; Dermatomycoses; Drug Resistance, Fungal; Endocarditis; Eye Infections; Humans; Hypocreales; Invasive Fungal Infections; Mycetoma; Mycoses; Onychomycosis; Opportunistic Infections; Osteomyelitis; Peritonitis; Respiratory Tract Infections; Voriconazole | 2020 |
Rhodotorula minuta as onychomycosis agent in a Chinese patient: first report and literature review.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Asian People; China; Drug Resistance, Fungal; Female; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Onychomycosis; Pyrimidines; Rhodotorula; Triazoles; Voriconazole | 2014 |
Onychomycosis.
Topics: Administration, Cutaneous; Administration, Oral; Antifungal Agents; Ciclopirox; Drug Administration Schedule; Drug Therapy, Combination; Fluconazole; Foot Dermatoses; Humans; Itraconazole; Mitosporic Fungi; Morpholines; Naphthalenes; Onychomycosis; Pyridones; Pyrimidines; Terbinafine; Thiazoles; Triazoles; Voriconazole | 2010 |
12 other study(ies) available for voriconazole and Onychomycosis
| Article | Year |
|---|---|
Antifungal effect of (R) and (S)-citronellal enantiomers and their predictive mechanism of action on Candida albicans from voriconazole-resistant onychomycoses.
Topics: Antifungal Agents; Candida albicans; Molecular Docking Simulation; Onychomycosis; Voriconazole | 2023 |
A successful management of fungal peritonitis caused by Rhodotorula glutinis in CAPD patient, coincident with onychomycosis by Penicillium sp: Case report.
Topics: Adult; Dialysis Solutions; Fluconazole; Humans; Male; Mycoses; Onychomycosis; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Voriconazole | 2023 |
Successful treatment of resistant onychomycosis with voriconazole in a liver transplant patient.
Topics: Antifungal Agents; Humans; Itraconazole; Liver Transplantation; Onychomycosis; Terbinafine; Voriconazole | 2020 |
Identification and in vitro antifungal susceptibility of causative agents of onychomycosis due to Aspergillus species in Mashhad, Iran.
Topics: Antifungal Agents; Aspergillus; Calmodulin; Fungal Proteins; Humans; Iran; Microbial Sensitivity Tests; Nitriles; Onychomycosis; Pyridines; Sequence Analysis, DNA; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Triazoles; Tubulin; Voriconazole | 2021 |
Enhanced nail delivery of voriconazole-loaded nanomicelles by thioglycolic acid pretreatment: A study of protein dynamics and disulfide bond rupture.
Topics: Animals; Disulfides; Nails; Onychomycosis; Swine; Thioglycolates; Voriconazole | 2021 |
Genetic diversity and antifungal susceptibility of Fusarium isolates in onychomycosis.
Topics: Amphotericin B; Antifungal Agents; Female; Fluconazole; Fusariosis; Fusarium; Genetic Variation; Humans; Itraconazole; Microbial Sensitivity Tests; Nails; Naphthalenes; Onychomycosis; Terbinafine; Voriconazole | 2017 |
Antimold Prophylaxis May Reduce the Risk of Invasive Fusariosis in Hematologic Patients with Superficial Skin Lesions with Positive Culture for Fusarium.
Topics: Adolescent; Adult; Aged; Anemia, Aplastic; Antifungal Agents; Female; Fusariosis; Fusarium; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Intertrigo; Leukemia; Male; Middle Aged; Onychomycosis; Prospective Studies; Skin; Triazoles; Voriconazole; Young Adult | 2016 |
In vitro activity of fluconazole, itraconazole, voriconazole and terbinafine against fungi causing onychomycosis.
Topics: Analysis of Variance; Antifungal Agents; Arthrodermataceae; Candida; Colombia; Dose-Response Relationship, Drug; Fluconazole; Fungi; Fusarium; Humans; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Onychomycosis; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2010 |
A case of fusariosis in an immunocompromised patient successfully treated with liposomal amphotericin B.
Topics: Abscess; Amphotericin B; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Combined Modality Therapy; Cytarabine; Foot Dermatoses; Fusarium; Humans; Imatinib Mesylate; Immunocompromised Host; Liposomes; Male; Middle Aged; Muscular Diseases; Onychomycosis; Peripheral Blood Stem Cell Transplantation; Piperazines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Recurrence; Remission Induction; Reoperation; Rituximab; Teniposide; Triazoles; Voriconazole | 2006 |
[Therapy with voriconazol for a case of chronic mucocutaneous candidiasis].
Topics: Adult; Antifungal Agents; Candidiasis, Chronic Mucocutaneous; Drug Resistance, Multiple, Fungal; Female; Humans; Onychomycosis; Pyrimidines; Triazoles; Voriconazole | 2006 |
[Bilateral proximal cellulitis and onychomycosis in both big toes due to Fusarium solani].
Topics: Antifungal Agents; Cellulitis; Ciclopirox; Diabetes Mellitus, Type 2; Disease Susceptibility; Drug Resistance, Multiple, Fungal; Foot Dermatoses; Fusarium; Humans; Imidazoles; Immunocompetence; Itraconazole; Male; Middle Aged; Mozambique; Onychomycosis; Pyridones; Pyrimidines; Recurrence; Toes; Travel; Triazoles; Urea; Voriconazole | 2006 |
In vitro activity of voriconazole against dermatophytes, Scopulariopsis brevicaulis and other opportunistic fungi as agents of onychomycosis.
Topics: Antifungal Agents; Arthrodermataceae; Drug Resistance, Multiple, Fungal; Fluconazole; Humans; Microbial Sensitivity Tests; Onychomycosis; Pyrimidines; Triazoles; Voriconazole | 2007 |